Human interleukin-4-dependent facilitation of human IgG production in PBL-NOG-hIL-4-Tg mice
Immune-humanized mouse models are indispensable tools for evaluating human immune responses and testing immune-based therapies; however, the induction of robust human antigen-specific immunoglobulin G (IgG) production remains limited due to species-specific incompatibilities. To investigate how human interleukin-4 (IL-4) promotes antibody responses, we employed NOG-hIL-4 transgenic mice (NOG-hIL-4-Tg), which constitutively express human IL-4, and transplanted them with human peripheral blood mononuclear cells (PBMCs). Flow cytometry, histological analysis, and next-generation sequencing were used to assess human lymphocyte maintenance, receptor repertoire diversity, class switching, and antigen-specific responses following immunization with peptide antigens. Sustained human B cell maintenance correlated with defined supraphysiological ranges of plasma hIL-4 concentrations. T and B cell receptor repertoire analyses demonstrated stable clonal diversity for one month after engraftment, followed by contraction by three months. Immunoglobulin repertoire profiling revealed IL-4-dependent class switching to IgG, with early predominance of IgG3 that declined over time and a gradual increase in IgG1, though subclass distribution varied among donors. Immunization induced antigen-reactive IgG, although many clones displayed low-affinity or cross-reactive binding, consistent with limited affinity maturation. Histological examination revealed tertiary lymphoid structure-like accumulations of human B and T cells within the spleen, without fully developed germinal centers. These findings demonstrate that human IL-4 expression in NOG-hIL-4-Tg mice supports human B cell survival, class switching, and partial IgG maturation, providing a relevant platform for studying human humoral immunity and evaluating antibody-based immunotherapies.
Authors
- Hitoshi Ishimoto (ORCID: https://orcid.org/0009-0006-5581-2278)
- Shunsuke Nakada
- Yasutaka Hoshino (ORCID: https://orcid.org/0000-0002-8300-4837)
- Yoshie Kametani (ORCID: https://orcid.org/0000-0002-7417-1836)
- Tomotaka Mabuchi (ORCID: https://orcid.org/0000-0002-0945-1137)
- Tomoka Shimizu
- Ayako Hirota
- Yusuke Ohno (ORCID: https://orcid.org/0000-0002-6744-4963)
- Ruri Ohki
- Shino Ohshima (ORCID: https://orcid.org/0000-0003-0825-6572)
- Ryoji Ito (ORCID: https://orcid.org/0000-0003-2903-2332)
- Soga Yamada
- Nagi Katano
- Hirofumi Kashiwagi
- Atsushi Yasuda (ORCID: https://orcid.org/0000-0002-7397-766X)
- Banri Tsuda (ORCID: https://orcid.org/0000-0003-3757-7914)
- Takashi Shiina (ORCID: https://orcid.org/0000-0002-2067-6708)
- Jerzy K. Kulski (ORCID: https://orcid.org/0000-0002-9789-245X)
- Mika Kojima
- Daiki Kirigaya
- Asuka Miyamoto (ORCID: https://orcid.org/0000-0003-4841-9292)
- Yusuke Kikuchi
- Mariko Miyazawa
- Yukio Nakamura
- Mao Suzuki-Ohno
Institutions
- Tokai University (JP)
- The University of Western Australia (AU)
- Central Institute for Experimental Animals (JP)
- Tokai University Hospital (JP)
- Genesis Research Institute (JP)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-11-26
- DOI
- https://doi.org/10.3389/fimmu.2025.1670682
- Primary Topic
- T-cell and B-cell Immunology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Agency for Medical Research and Development
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Society for the Promotion of Science